
- Pharmaceutical Technology, November 2022
- Volume 46
- Issue 11
- Pages: 12
Microbubble-Enabled Isolation Kit
Akadeum’s Life Sciences isolation kit uses microbubbles to reduce leukopak production time.
Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation kit is a research-use-only kit developed to address various biological and workflow challenges in large-volume cell separation workflows. The kit uses a technology combining microbubbles with a buoyancy-activated cell sorting separation tube to produce nearly two leukopaks,which are blood bags containing billions of white blood cells, in one hour.
Akadeum’s patented microbubble technology uses low-density particles to float targeted cells to the top of a sample. In addition to reducing the time necessary to produce leukopaks, the technology is also designed to promote the health and physiology of the
cells, allow for minimal handling, increase throughput, and enable less pre-processing.
Articles in this issue
over 3 years ago
Streamlining Equipment Quality and Flexibilityover 3 years ago
Excipients for Solubility Enhancement of Parenteral Formulationsover 3 years ago
Putting a Spotlight on Particle Engineeringover 3 years ago
Examining Trends in Oral Solid Dosage Manufacturingover 3 years ago
Updated Guidance to the European Data Governance Actover 3 years ago
Trial DeclineNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




